Intended Business Use: Foundation for Risk-Based Validation

Build Accurate Statements That Enable Vendor Leverage and Focus Client Validation Scope

Vague Intended Use Statements Prevent Validation Leverage and Scope Reduction

For vendors: generic intended use statements don't give clients a clear baseline to compare against, making your comprehensive OQ hard to leverage. For clients: you can't determine validation gaps without knowing how your use differs from the vendor's tested configuration. Either way, you end up with comprehensive testing because you can't defend scope reduction decisions.

  • Vendor competitive advantage - tie URS, baseline configuration, and OQ into clear statements that reduce client validation by months
  • Client gap identification - determine intended use differentials, client-specific configurations, and workflow validation needs
  • Validation leverage - clients know exactly where vendor OQ covers their needs vs. where PQ must focus
  • Upgrade management - clear intended use minimizes client revalidation burden for frequent upgrades
  • Risk-based scope - intended use drives CDEs, risk assessment, and testing depth decisions
Book a Free Consultation
Call Direct: (267) 204-3524
Email:
or
×

Operationalized Through ValKit Digital Validation Platform

Driftpin builds the Intended Business Use framework. ValKit operationalizes it, structuring validation packages so CDEs and risk assessments flow directly from intended use definition.

•
Enforced sequence - intended use must be documented before building CDEs or risk assessments
•
Vendor baseline management - vendors maintain OQ baseline documentation clients can reference and leverage
•
Client gap analysis - map actual use against vendor baselines to determine PQ focus areas

What We Deliver

Driftpin specializes in creating validation strategies that are pragmatic, right-sized, and efficient. That starts with Intended Business Use statements that actually drive validation scope decisions.

For vendors: Your validation documentation becomes a competitive asset. We help you tie together URS, Default Configuration Specification, and OQ package into clear Intended Business Use statements that clients can actually use. When clients can immediately identify where your comprehensive OQ covers their needs versus where they need focused PQ, you’ve differentiated yourself—especially critical for newer products requiring frequent upgrades where clear intended use minimizes client revalidation burden.

For clients: Your validation scope becomes defensible. We help you define your actual Intended Business Use and map it against vendor baselines. Your PQ then focuses on three specific areas: where your intended use differs from vendor baseline, your client-specific configurations, and your specific workflows. You’re not redoing vendor OQ—you’re testing what actually requires validation in your deployment.

The result: Intended use statements that drive CDEs, risk assessment, and testing scope decisions. Built into Valkit workflows that enforce the thinking sequence making risk-based validation defensible.

Why This Works

25 Years GxP Validation Experience

Built Intended Business Use frameworks for vendors and clients across pharma, biotech, medical device, and CRO organizations

CSA Implementation Expertise

Deep understanding of how intended use drives the complete CSA framework: CDEs, risk assessment, testing scope, and vendor leverage

ValKit Advisory Board

Platform expertise to operationalize intended use frameworks through structured digital workflows that enforce proper validation sequence

Our Approach

  1. Current State Assessment: Review existing intended use documentation and validation approach
  2. Vendor Baseline Definition: Document vanilla configuration, URS alignment, and OQ coverage (for vendors)
  3. Client Use Mapping: Define actual use and identify intended use differentials, configurations, and workflows (for clients)
  4. Gap Analysis: Determine where vendor OQ provides coverage and where client PQ must focus
  5. ValKit Implementation: Structure validation packages around intended use with CDE identification and risk assessment flows

Ready to Build Intended Use Statements That Enable Risk-Based Validation?

Book Your Consultation